PEPPERMINT OIL

PEPPERMINT OIL was reported 1116 times

PEPPERMINT OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 23 0.1285
1 ACCESSORY SPLEEN 5 0.0556
2 BLADDER ADENOCARCINOMA STAGE UNSPECIFIED 2 0.0426
3 INFUSION SITE STREAKING 3 0.0345
4 HYPOPHENYLALANINAEMIA 1 0.0312
5 FAT REDISTRIBUTION 5 0.0216
6 END-TIDAL CO2 DECREASED 1 0.0213
7 ELECTROENCEPHALOGRAM 1 0.0179
8 OBSTRUCTIVE SLEEP APNOEA SYNDROME 23 0.0158
9 BURSA INJURY 1 0.0154
10 MYOGLOBIN BLOOD INCREASED 23 0.0150
11 CORTISOL FREE URINE INCREASED 1 0.0149
12 BURNING FEET SYNDROME 3 0.0120
13 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 2 0.0107
14 ADRENALECTOMY 1 0.0102
15 CEREBRAL VASCULAR OCCLUSION 1 0.0087
16 MALABSORPTION FROM ADMINISTRATION SITE 2 0.0086
17 LACRIMATION DISORDER 1 0.0082
18 INCISION SITE ABSCESS 2 0.0077
19 BRAIN NATRIURETIC PEPTIDE INCREASED 23 0.0075
20 VULVAL ABSCESS 3 0.0073
21 LYMPHOCYTIC HYPOPHYSITIS 2 0.0072
22 PLANTAR FASCIITIS 24 0.0071
23 PERINEAL PAIN 5 0.0070
24 DIAPHRAGMATIC SPASM 1 0.0068
25 FALLOPIAN TUBE CYST 1 0.0062
26 CHONDROCALCINOSIS 4 0.0061
27 ANAL SKIN TAGS 1 0.0061
28 HEMIPLEGIC MIGRAINE 2 0.0059
29 LITHOTRIPSY 1 0.0059
30 TEMPORAL ARTERITIS 5 0.0054
31 STOOL ANALYSIS ABNORMAL 2 0.0053
32 GASTROSTOMY TUBE INSERTION 1 0.0052
33 BACTERIAL DIARRHOEA 1 0.0047
34 RAPID EYE MOVEMENTS SLEEP ABNORMAL 2 0.0047
35 DEVICE LOOSENING 4 0.0046
36 INCREASED UPPER AIRWAY SECRETION 23 0.0045
37 PROCEDURAL ANXIETY 3 0.0044
38 LIGAMENT INJURY 5 0.0044
39 RECTAL ULCER 5 0.0043
40 ENVIRONMENTAL EXPOSURE 1 0.0042
41 HELMINTHIC INFECTION 1 0.0041
42 OROPHARYNGEAL SWELLING 4 0.0041
43 RETROGRADE AMNESIA 2 0.0040
44 BENIGN BREAST NEOPLASM 4 0.0039
45 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
46 FOREIGN BODY IN THROAT 12 0.0038
47 ENZYME ABNORMALITY 2 0.0037
48 GENITAL BLISTER 1 0.0036
49 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
50 URTICARIA CHRONIC 2 0.0036
51 FEMALE GENITAL TRACT FISTULA 6 0.0035
52 IMPLANT SITE INFLAMMATION 1 0.0034
53 DUODENAL OBSTRUCTION 1 0.0033
54 HYPNAGOGIC HALLUCINATION 1 0.0033
55 DISORGANISED SPEECH 6 0.0033
56 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
57 PATIENT-DEVICE INCOMPATIBILITY 2 0.0029
58 ADMINISTRATION SITE BRUISE 1 0.0029
59 FOREARM FRACTURE 2 0.0029
60 SENSATION OF FOREIGN BODY 24 0.0028
61 PARASOMNIA 2 0.0028
62 OPHTHALMIC HERPES ZOSTER 5 0.0028
63 DIABETIC GASTROPARESIS 1 0.0027
64 EXOSTOSIS 24 0.0026
65 ORAL MUCOSAL ERYTHEMA 4 0.0026
66 LARYNGEAL PAIN 1 0.0025
67 HIGH FREQUENCY ABLATION 1 0.0025
68 AORTIC OCCLUSION 1 0.0024
69 LISTLESS 8 0.0024
70 PERSECUTORY DELUSION 6 0.0024
71 MELANOMA RECURRENT 1 0.0024
72 ALLERGY TO PLANTS 1 0.0022
73 BLOOD UREA ABNORMAL 2 0.0021
74 INTUSSUSCEPTION 2 0.0021
75 OBSTRUCTIVE AIRWAYS DISORDER 23 0.0021
76 HEPATIC CYST 7 0.0021
77 SPINAL LAMINECTOMY 2 0.0020
78 SLEEP PARALYSIS 3 0.0020
79 PRECANCEROUS SKIN LESION 3 0.0020
80 HYPERMOBILITY SYNDROME 1 0.0020
81 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
82 WAIST CIRCUMFERENCE INCREASED 2 0.0019
83 FAECAL VOLUME INCREASED 1 0.0019
84 LIGAMENT PAIN 1 0.0019
85 WHITE BLOOD CELL DISORDER 5 0.0019
86 INFECTED FISTULA 1 0.0019
87 BRONCHOSPASM 26 0.0018
88 HYPERTENSIVE URGENCY 1 0.0018
89 DEVICE MAINTENANCE ISSUE 1 0.0017
90 ADENOMYOSIS 1 0.0017
91 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
92 RECTAL PROLAPSE 2 0.0017
93 BODY TEMPERATURE ABNORMAL 3 0.0016
94 INJECTION SITE LACERATION 1 0.0016
95 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
96 LOOSE TOOTH 5 0.0016
97 SECRETION DISCHARGE 19 0.0015
98 BRONCHITIS VIRAL 1 0.0015
99 PNEUMOTHORAX 23 0.0014
100 MAST CELL ACTIVATION SYNDROME 2 0.0014
101 FUNGAL OESOPHAGITIS 1 0.0014
102 DERMATITIS DIAPER 1 0.0014
103 INFUSION SITE INFLAMMATION 1 0.0014
104 CATAPLEXY 2 0.0014
105 GASTROINTESTINAL SCARRING 1 0.0014
106 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
107 BLUNTED AFFECT 1 0.0014
108 BRONCHITIS BACTERIAL 1 0.0013
109 HAEMATOCRIT INCREASED 3 0.0013
110 EOSINOPHILIA 23 0.0013
111 GASTROINTESTINAL SURGERY 1 0.0013
112 BLOOD ALCOHOL INCREASED 1 0.0013
113 SINUS OPERATION 3 0.0013
114 LIP ERYTHEMA 1 0.0013
115 EROSIVE DUODENITIS 1 0.0013
116 VULVOVAGINAL PAIN 6 0.0012
117 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
118 PITUITARY TUMOUR BENIGN 2 0.0012
119 FEAR OF FALLING 1 0.0012
120 EXTRAVASATION 5 0.0012
121 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
122 FUNGAL SEPSIS 1 0.0012
123 DENTAL DISCOMFORT 1 0.0012
124 CRANIOFACIAL FRACTURE 1 0.0012
125 ALLERGIC SINUSITIS 1 0.0012
126 SPONDYLOLISTHESIS 2 0.0012
127 COMPARTMENT SYNDROME 3 0.0011
128 INFUSION SITE DISCHARGE 2 0.0011
129 BLOOD LACTIC ACID INCREASED 6 0.0011
130 PANCREATIC FAILURE 2 0.0011
131 ANORECTAL DISCOMFORT 6 0.0011
132 ABDOMINAL RIGIDITY 3 0.0011
133 LARGE INTESTINAL ULCER 3 0.0011
134 BONE CONTUSION 1 0.0011
135 VAGINAL INFECTION 5 0.0011
136 SKIN ABRASION 5 0.0011
137 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
138 BLOOD URINE 1 0.0010
139 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
140 COMA SCALE ABNORMAL 3 0.0010
141 BILIARY COLIC 3 0.0010
142 ANIMAL SCRATCH 1 0.0010
143 DEVICE RELATED THROMBOSIS 1 0.0010
144 POLYDIPSIA 4 0.0010
145 AUTONOMIC NEUROPATHY 1 0.0010
146 PETIT MAL EPILEPSY 5 0.0010
147 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
148 MYOCARDITIS 11 0.0010
149 CONSCIOUSNESS FLUCTUATING 1 0.0010
150 SELF-INJURIOUS IDEATION 4 0.0010
151 HYPOPERFUSION 1 0.0010
152 INCONTINENCE 10 0.0009
153 ANAL FISTULA 5 0.0009
154 PROCTALGIA 6 0.0009
155 IDIOPATHIC URTICARIA 1 0.0009
156 STREPTOCOCCAL INFECTION 5 0.0009
157 INFECTIOUS MONONUCLEOSIS 2 0.0009
158 BLADDER OPERATION 1 0.0009
159 POLYURIA 7 0.0009
160 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
161 BRONCHIAL HYPERREACTIVITY 1 0.0008
162 BLADDER PROLAPSE 1 0.0008
163 VENTRICULAR FIBRILLATION 9 0.0008
164 STAPHYLOCOCCAL SEPSIS 4 0.0008
165 MALIGNANT MELANOMA IN SITU 1 0.0008
166 INTERVERTEBRAL DISC OPERATION 1 0.0008
167 SNORING 3 0.0008
168 BRONCHIAL SECRETION RETENTION 1 0.0008
169 LACTOSE INTOLERANCE 2 0.0008
170 DYSPNOEA EXERTIONAL 29 0.0008
171 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
172 CORONARY ARTERY DISEASE 23 0.0008
173 SKIN PAPILLOMA 3 0.0007
174 BLOOD SODIUM INCREASED 2 0.0007
175 PERIPHERAL VENOUS DISEASE 3 0.0007
176 AGORAPHOBIA 1 0.0007
177 IMMUNOGLOBULINS DECREASED 1 0.0007
178 HEAD TITUBATION 1 0.0007
179 CIRCULATORY COLLAPSE 12 0.0007
180 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
181 FAT TISSUE INCREASED 1 0.0007
182 NAIL DISORDER 6 0.0007
183 DARK CIRCLES UNDER EYES 1 0.0007
184 COCCYDYNIA 1 0.0007
185 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
186 INFUSION SITE REACTION 2 0.0007
187 ATYPICAL PNEUMONIA 2 0.0007
188 HYDRONEPHROSIS 5 0.0007
189 CENTRAL VENOUS CATHETERISATION 2 0.0007
190 ASTIGMATISM 1 0.0007
191 HAEMOGLOBIN INCREASED 3 0.0007
192 DYSCHEZIA 2 0.0007
193 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
194 IRRITABLE BOWEL SYNDROME 14 0.0007
195 GENERALISED OEDEMA 8 0.0006
196 APHTHOUS ULCER 5 0.0006
197 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
198 BACTERIAL VAGINOSIS 1 0.0006
199 BLOOD CREATININE DECREASED 2 0.0006
200 MEDICAL DEVICE IMPLANTATION 1 0.0006
201 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
202 INFUSION SITE PRURITUS 2 0.0006
203 HEPATITIS E 1 0.0006
204 COLITIS MICROSCOPIC 3 0.0006
205 PHOTOPSIA 4 0.0006
206 INAPPROPRIATE AFFECT 1 0.0006
207 BLADDER PAIN 2 0.0006
208 JC VIRUS INFECTION 1 0.0006
209 HYPERPROLACTINAEMIA 4 0.0006
210 COSTOCHONDRITIS 1 0.0006
211 BREAST ENLARGEMENT 2 0.0006
212 INJECTION SITE ATROPHY 1 0.0006
213 INFUSION SITE HAEMORRHAGE 2 0.0006
214 NEAR DEATH EXPERIENCE 2 0.0006
215 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
216 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 1 0.0006
217 EXPOSURE TO SARS-COV-2 1 0.0006
218 CHOREA 1 0.0006
219 CERVICAL VERTEBRAL FRACTURE 2 0.0006
220 BURNS SECOND DEGREE 1 0.0006
221 WHEEZING 33 0.0006
222 CUTANEOUS VASCULITIS 2 0.0005
223 GASTROINTESTINAL PAIN 6 0.0005
224 PARADOXICAL DRUG REACTION 2 0.0005
225 CYSTIC FIBROSIS 3 0.0005
226 LOSS OF CONTROL OF LEGS 2 0.0005
227 ARTERIAL DISORDER 1 0.0005
228 MUSCULOSKELETAL CHEST PAIN 8 0.0005
229 IMPAIRED GASTRIC EMPTYING 7 0.0005
230 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
231 INFLAMMATORY BOWEL DISEASE 5 0.0005
232 PNEUMONIA FUNGAL 2 0.0005
233 SKIN ULCER 13 0.0005
234 GINGIVAL PAIN 4 0.0005
235 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
236 VAGINAL DISCHARGE 5 0.0005
237 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
238 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
239 CHEST DISCOMFORT 49 0.0005
240 INFUSION SITE SWELLING 3 0.0005
241 EYE CONTUSION 1 0.0005
242 MUSCLE FATIGUE 2 0.0005
243 ABSCESS LIMB 2 0.0005
244 VITAMIN D DECREASED 4 0.0005
245 MEDICAL DEVICE PAIN 1 0.0005
246 TEARFULNESS 2 0.0005
247 METASTATIC NEOPLASM 2 0.0005
248 MENSTRUATION DELAYED 5 0.0005
249 TOOTH FRACTURE 5 0.0005
250 RESPIRATORY RATE INCREASED 4 0.0005
251 RHINITIS ALLERGIC 2 0.0004
252 BACTERIAL TEST POSITIVE 1 0.0004
253 GOUT 8 0.0004
254 HALLUCINATION, AUDITORY 7 0.0004
255 PANIC ATTACK 16 0.0004
256 JOINT EFFUSION 3 0.0004
257 HYPOMAGNESAEMIA 6 0.0004
258 INFUSION SITE INFECTION 1 0.0004
259 POST PROCEDURAL HAEMORRHAGE 5 0.0004
260 MASS 6 0.0004
261 DISCOURAGEMENT 1 0.0004
262 CONTRAST MEDIA REACTION 1 0.0004
263 INGROWING NAIL 1 0.0004
264 FLATULENCE 24 0.0004
265 DIVERTICULUM 3 0.0004
266 FEAR OF INJECTION 3 0.0004
267 EOSINOPHIL COUNT DECREASED 1 0.0004
268 ENDOMETRIOSIS 2 0.0004
269 FAECAL INCONTINENCE 2 0.0004
270 DYSPHONIA 24 0.0004
271 DENTAL OPERATION 1 0.0004
272 MUCOUS STOOLS 2 0.0004
273 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
274 INSTILLATION SITE PAIN 1 0.0004
275 DEVICE INFUSION ISSUE 1 0.0004
276 LABYRINTHITIS 1 0.0004
277 BOWEL MOVEMENT IRREGULARITY 3 0.0004
278 ABDOMINAL INFECTION 1 0.0004
279 DISSOCIATION 3 0.0004
280 MEAN CELL VOLUME INCREASED 1 0.0004
281 INFUSION SITE PAIN 5 0.0004
282 MEDICATION RESIDUE 1 0.0004
283 GASTROENTERITIS VIRAL 7 0.0004
284 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
285 TRISMUS 2 0.0004
286 ACTINIC KERATOSIS 1 0.0004
287 HERNIA REPAIR 1 0.0004
288 WEIGHT FLUCTUATION 4 0.0004
289 RENAL CYST 3 0.0004
290 AGRANULOCYTOSIS 7 0.0004
291 PHARYNGOLARYNGEAL PAIN 2 0.0004
292 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
293 FOOD POISONING 2 0.0004
294 ALCOHOL POISONING 1 0.0004
295 ANAL FISSURE 2 0.0004
296 POOR QUALITY SLEEP 8 0.0004
297 URINARY INCONTINENCE 11 0.0004
298 ASTHENOPIA 2 0.0004
299 EOSINOPHILIC OESOPHAGITIS 1 0.0004
300 CHOLECYSTITIS INFECTIVE 1 0.0004
301 HAEMORRHOIDS 7 0.0004
302 DIABETIC COMA 1 0.0004
303 DRUG TOLERANCE DECREASED 1 0.0004
304 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
305 DUODENAL ULCER HAEMORRHAGE 1 0.0003
306 RECTAL HAEMORRHAGE 15 0.0003
307 ANGINA PECTORIS 10 0.0003
308 MUSCULOSKELETAL DISCOMFORT 6 0.0003
309 FIBULA FRACTURE 1 0.0003
310 SKIN WARM 2 0.0003
311 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
312 ENERGY INCREASED 2 0.0003
313 SKIN HAEMORRHAGE 5 0.0003
314 ANAL INCONTINENCE 3 0.0003
315 LOSS OF EMPLOYMENT 1 0.0003
316 LUPUS-LIKE SYNDROME 3 0.0003
317 RESTLESS LEGS SYNDROME 6 0.0003
318 EMERGENCY CARE 1 0.0003
319 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
320 MEDICAL DEVICE DISCOMFORT 1 0.0003
321 DUODENITIS 1 0.0003
322 NERVE COMPRESSION 3 0.0003
323 FAMILY STRESS 1 0.0003
324 BACTERIAL INFECTION 6 0.0003
325 NASAL DRYNESS 2 0.0003
326 RASH MACULAR 11 0.0003
327 SLEEP APNOEA SYNDROME 6 0.0003
328 AUTOIMMUNE DISORDER 3 0.0003
329 PHARYNGEAL SWELLING 3 0.0003
330 SINUS DISORDER 6 0.0003
331 CARDIAC DISORDER 28 0.0003
332 TOOTH ABSCESS 3 0.0003
333 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
334 AKATHISIA 4 0.0003
335 BRONCHOPNEUMONIA 1 0.0003
336 HEPATIC FIBROSIS 1 0.0003
337 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
338 LYMPHOEDEMA 2 0.0003
339 DEPRESSION SUICIDAL 1 0.0003
340 LARGE INTESTINE POLYP 2 0.0003
341 HYPOPNOEA 1 0.0003
342 HYPERTRANSAMINASAEMIA 2 0.0003
343 CAROTID ARTERY STENOSIS 1 0.0003
344 CARPAL TUNNEL SYNDROME 4 0.0003
345 HYPERKALAEMIA 10 0.0003
346 HANGOVER 1 0.0003
347 LOGORRHOEA 1 0.0003
348 DUODENAL ULCER 2 0.0003
349 OSTEOARTHRITIS 12 0.0003
350 HAND FRACTURE 2 0.0003
351 FIBRIN D DIMER INCREASED 1 0.0003
352 HAEMORRHAGIC DIATHESIS 1 0.0003
353 BODY HEIGHT DECREASED 3 0.0003
354 NIGHT SWEATS 9 0.0003
355 GASTROINTESTINAL DISORDER 25 0.0003
356 ATRIAL FIBRILLATION 27 0.0003
357 CAROTID ARTERY OCCLUSION 1 0.0003
358 BLOOD PHOSPHORUS DECREASED 1 0.0003
359 HYPOMANIA 1 0.0003
360 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
361 HYPERACUSIS 1 0.0003
362 CHRONIC SINUSITIS 1 0.0003
363 TENDON PAIN 2 0.0003
364 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
365 MICTURITION URGENCY 3 0.0003
366 INSURANCE ISSUE 4 0.0003
367 COMMUNICATION DISORDER 1 0.0003
368 GASTRIC INFECTION 1 0.0003
369 GINGIVAL DISORDER 1 0.0003
370 FREQUENT BOWEL MOVEMENTS 7 0.0003
371 FOOD ALLERGY 2 0.0003
372 ABDOMINAL DISTENSION 27 0.0003
373 FAECES HARD 1 0.0003
374 CARDIOPULMONARY FAILURE 1 0.0003
375 SWOLLEN TONGUE 8 0.0003
376 NASAL DISCOMFORT 2 0.0003
377 TRICUSPID VALVE INCOMPETENCE 2 0.0003
378 HYPONATRAEMIA 14 0.0002
379 FRUSTRATION TOLERANCE DECREASED 2 0.0002
380 BURSITIS 3 0.0002
381 ADRENAL INSUFFICIENCY 3 0.0002
382 GALLBLADDER OPERATION 1 0.0002
383 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
384 NASOPHARYNGITIS 45 0.0002
385 SINUSITIS 25 0.0002
386 PHARYNGITIS 3 0.0002
387 DERMATITIS ALLERGIC 3 0.0002
388 INFUSION SITE ERYTHEMA 2 0.0002
389 MUSCLE ATROPHY 3 0.0002
390 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
391 INTERVERTEBRAL DISC DISORDER 1 0.0002
392 ROTATOR CUFF SYNDROME 3 0.0002
393 MIGRAINE 22 0.0002
394 DYSGEUSIA 17 0.0002
395 DYSPHEMIA 1 0.0002
396 IMMUNE SYSTEM DISORDER 3 0.0002
397 SARS-COV-2 TEST POSITIVE 3 0.0002
398 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
399 LIGAMENT RUPTURE 1 0.0002
400 ABDOMINAL ABSCESS 1 0.0002
401 LETHARGY 13 0.0002
402 HEAD DISCOMFORT 4 0.0002
403 CATHETERISATION CARDIAC 1 0.0002
404 BRAIN NEOPLASM MALIGNANT 1 0.0002
405 QUALITY OF LIFE DECREASED 3 0.0002
406 GASTROINTESTINAL INFECTION 2 0.0002
407 PARAESTHESIA 35 0.0002
408 CONSTIPATION 48 0.0002
409 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
410 EAR DISORDER 1 0.0002
411 ANAPHYLACTIC REACTION 12 0.0002
412 DIVERTICULITIS 6 0.0002
413 PROCEDURAL PAIN 6 0.0002
414 LOCALISED OEDEMA 1 0.0002
415 HEPATIC STEATOSIS 4 0.0002
416 FEELING OF DESPAIR 1 0.0002
417 DIARRHOEA HAEMORRHAGIC 2 0.0002
418 PALPITATIONS 25 0.0002
419 IMPAIRED HEALING 7 0.0002
420 TARDIVE DYSKINESIA 6 0.0002
421 PHOTOPHOBIA 4 0.0002
422 SQUAMOUS CELL CARCINOMA 2 0.0002
423 HALLUCINATION 16 0.0002
424 BLOOD SODIUM DECREASED 4 0.0002
425 BLOOD PROLACTIN INCREASED 1 0.0002
426 SPINAL DISORDER 2 0.0002
427 COLITIS 8 0.0002
428 FUNGAL INFECTION 7 0.0002
429 SYNCOPE 21 0.0002
430 EYE INFLAMMATION 2 0.0002
431 PRODUCTIVE COUGH 10 0.0002
432 HYPOVOLAEMIC SHOCK 1 0.0002
433 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
434 ATELECTASIS 2 0.0002
435 LOCALISED INFECTION 5 0.0002
436 EAR PAIN 4 0.0002
437 FIBROMYALGIA 5 0.0002
438 APATHY 3 0.0002
439 PARKINSONISM 2 0.0002
440 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
441 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
442 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
443 OEDEMA 11 0.0002
444 BREATH SOUNDS ABNORMAL 1 0.0002
445 OSTEONECROSIS OF JAW 5 0.0002
446 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
447 HEPATIC ENZYME ABNORMAL 1 0.0002
448 OVARIAN CYST 2 0.0002
449 HEART RATE DECREASED 7 0.0002
450 CONFUSIONAL STATE 32 0.0002
451 OSTEOPENIA 3 0.0002
452 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
453 FEEDING DISORDER 4 0.0002
454 DRY THROAT 2 0.0002
455 NEUTROPHIL COUNT INCREASED 2 0.0002
456 FEMORAL NECK FRACTURE 1 0.0002
457 TENDONITIS 3 0.0002
458 EJECTION FRACTION DECREASED 3 0.0002
459 FAILURE TO THRIVE 1 0.0002
460 RESPIRATORY TRACT INFECTION 5 0.0002
461 PETECHIAE 2 0.0002
462 BRAIN FOG 3 0.0002
463 NERVOUSNESS 10 0.0002
464 CATATONIA 1 0.0002
465 FOOD CRAVING 1 0.0002
466 RESPIRATORY TRACT CONGESTION 3 0.0002
467 RENAL PAIN 2 0.0002
468 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
469 DYSARTHRIA 7 0.0002
470 GINGIVITIS 1 0.0002
471 ABDOMINAL DISCOMFORT 31 0.0002
472 ABDOMINAL PAIN UPPER 38 0.0002
473 BACK DISORDER 3 0.0002
474 SKIN LACERATION 2 0.0002
475 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
476 METASTASES TO BONE 3 0.0002
477 JAW DISORDER 1 0.0002
478 ANGIOEDEMA 8 0.0002
479 DENTAL CARIES 2 0.0002
480 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
481 TOOTH DISORDER 4 0.0002
482 MUSCLE SPASMS 33 0.0002
483 HEART RATE ABNORMAL 1 0.0002
484 MALNUTRITION 2 0.0002
485 SKIN INFECTION 2 0.0002
486 OCULAR DISCOMFORT 2 0.0002
487 DIARRHOEA 114 0.0002
488 CHOLECYSTITIS ACUTE 1 0.0002
489 ABDOMINAL PAIN 41 0.0002
490 HYPERSOMNIA 5 0.0002
491 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
492 HERPES VIRUS INFECTION 1 0.0002
493 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
494 METABOLIC DISORDER 1 0.0002
495 ELECTROLYTE IMBALANCE 2 0.0002
496 DYSSTASIA 5 0.0002
497 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
498 BLOOD IRON DECREASED 2 0.0002
499 CARDIAC PACEMAKER INSERTION 1 0.0002
500 MYOCLONUS 2 0.0002
501 BLOOD PRESSURE FLUCTUATION 4 0.0002
502 C-REACTIVE PROTEIN INCREASED 6 0.0002
503 COUGH 46 0.0002
504 AGITATION 12 0.0002
505 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
506 ABNORMAL WEIGHT GAIN 2 0.0002
507 GYNAECOMASTIA 5 0.0002
508 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
509 INFUSION SITE EXTRAVASATION 1 0.0002
510 SOMNOLENCE 32 0.0002
511 MUSCULOSKELETAL DISORDER 3 0.0002
512 FOREIGN BODY SENSATION IN EYES 1 0.0002
513 ENTERITIS 1 0.0002
514 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
515 ILLNESS 16 0.0002
516 HIATUS HERNIA 2 0.0002
517 LACTIC ACIDOSIS 5 0.0002
518 SWELLING FACE 10 0.0002
519 PLATELET COUNT INCREASED 2 0.0002
520 MYALGIA 26 0.0002
521 NEPHROLITHIASIS 7 0.0002
522 DYSPNOEA 86 0.0002
523 DYSGRAPHIA 1 0.0002
524 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
525 EAR INFECTION 4 0.0002
526 LIP SWELLING 5 0.0001
527 CARDIAC FAILURE ACUTE 1 0.0001
528 COGNITIVE DISORDER 7 0.0001
529 MENINGITIS 1 0.0001
530 BREAST MASS 1 0.0001
531 BRONCHIECTASIS 1 0.0001
532 COVID-19 26 0.0001
533 DISCOMFORT 9 0.0001
534 ECCHYMOSIS 1 0.0001
535 INFLUENZA LIKE ILLNESS 12 0.0001
536 PERIPHERAL COLDNESS 2 0.0001
537 HAIR GROWTH ABNORMAL 1 0.0001
538 DELIRIUM 5 0.0001
539 ORAL DISCOMFORT 2 0.0001
540 AUTOIMMUNE HEPATITIS 1 0.0001
541 HUNGER 2 0.0001
542 EXTRASYSTOLES 1 0.0001
543 DEFAECATION URGENCY 1 0.0001
544 MOUTH ULCERATION 3 0.0001
545 DIZZINESS 71 0.0001
546 TOXICITY TO VARIOUS AGENTS 24 0.0001
547 SEASONAL ALLERGY 2 0.0001
548 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
549 IMPAIRED QUALITY OF LIFE 2 0.0001
550 BALANCE DISORDER 12 0.0001
551 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
552 DERMATITIS BULLOUS 1 0.0001
553 FAECES SOFT 1 0.0001
554 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
555 GASTROENTERITIS 2 0.0001
556 NEUROPATHY PERIPHERAL 13 0.0001
557 NASAL CONGESTION 8 0.0001
558 HYPOPHOSPHATAEMIA 1 0.0001
559 CEREBRAL DISORDER 1 0.0001
560 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
561 ARTHROPOD BITE 1 0.0001
562 COLITIS ULCERATIVE 6 0.0001
563 IMMUNODEFICIENCY 2 0.0001
564 ECZEMA 7 0.0001
565 HAEMORRHAGE INTRACRANIAL 2 0.0001
566 ANXIETY 38 0.0001
567 ASTHMA 15 0.0001
568 NAUSEA 105 0.0001
569 JOINT SWELLING 16 0.0001
570 LACRIMATION INCREASED 4 0.0001
571 AORTIC ANEURYSM 1 0.0001
572 MUSCLE TWITCHING 3 0.0001
573 HYPOKALAEMIA 6 0.0001
574 DEVICE RELATED INFECTION 2 0.0001
575 ANKLE FRACTURE 2 0.0001
576 CONCUSSION 1 0.0001
577 RASH PRURITIC 7 0.0001
578 APNOEA 1 0.0001
579 BURNING SENSATION 9 0.0001
580 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
581 CYANOSIS 2 0.0001
582 BLOOD ALBUMIN DECREASED 1 0.0001
583 BACK PAIN 29 0.0001
584 BLOOD DISORDER 1 0.0001
585 FATIGUE 97 0.0001
586 BLOOD PRESSURE INCREASED 19 0.0001
587 DRY MOUTH 10 0.0001
588 FALL 41 0.0001
589 DECUBITUS ULCER 1 0.0001
590 MANIA 2 0.0001
591 OSTEOPOROSIS 5 0.0001
592 CARDIAC ARREST 10 0.0001
593 DRUG LEVEL INCREASED 2 0.0001
594 VISUAL ACUITY REDUCED 4 0.0001
595 DEHYDRATION 16 0.0001
596 POLLAKIURIA 5 0.0001
597 GAIT INABILITY 4 0.0001
598 BLOOD UREA INCREASED 2 0.0001
599 UNEVALUABLE EVENT 9 0.0001
600 ABDOMINAL PAIN LOWER 3 0.0001
601 CANDIDA INFECTION 2 0.0001
602 HYPOPHAGIA 3 0.0001
603 FACIAL PARALYSIS 1 0.0001
604 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
605 ANAPHYLACTIC SHOCK 3 0.0001
606 CARDIAC OPERATION 1 0.0001
607 INFLAMMATION 6 0.0001
608 HYPOACUSIS 5 0.0001
609 EXPOSURE VIA SKIN CONTACT 3 0.0001
610 VERTIGO 7 0.0001
611 WEIGHT DECREASED 32 0.0001
612 ARTHRITIS 9 0.0001
613 CONTUSION 11 0.0001
614 ANHEDONIA 3 0.0001
615 DEPRESSED MOOD 6 0.0001
616 SLEEP DISORDER 8 0.0001
617 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
618 TACHYCARDIA 10 0.0001
619 MALAISE 49 0.0001
620 HEADACHE 70 0.0001
621 FEAR 3 0.0001
622 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
623 THROAT IRRITATION 5 0.0001
624 PAIN OF SKIN 3 0.0001
625 URINARY TRACT INFECTION 19 0.0001
626 MOBILITY DECREASED 8 0.0001
627 LOSS OF LIBIDO 1 0.0001
628 HEAVY MENSTRUAL BLEEDING 1 0.0001
629 BLOOD BILIRUBIN INCREASED 3 0.0001
630 DEVELOPMENTAL DELAY 1 0.0001
631 TOOTHACHE 2 0.0001
632 RESTLESSNESS 4 0.0001
633 SUICIDAL IDEATION 10 0.0001
634 RESPIRATORY ARREST 3 0.0001
635 TINNITUS 5 0.0001
636 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
637 DYSURIA 4 0.0001
638 IRON DEFICIENCY ANAEMIA 1 0.0001
639 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
640 CHEST PAIN 20 0.0001
641 DEMENTIA 3 0.0001
642 BLOOD CHOLESTEROL INCREASED 5 0.0001
643 PSORIASIS 14 0.0001
644 EYE PAIN 6 0.0001
645 ARTERIOSCLEROSIS 1 0.0001
646 LEUKAEMIA 1 0.0001
647 PAIN IN JAW 3 0.0001
648 BLOOD PRESSURE DECREASED 7 0.0001
649 GASTRIC ULCER 2 0.0001
650 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
651 PROTEINURIA 2 0.0001
652 RED BLOOD CELL COUNT DECREASED 3 0.0001
653 RASH ERYTHEMATOUS 5 0.0001
654 ACUTE KIDNEY INJURY 16 0.0001
655 GLAUCOMA 2 0.0001
656 DRUG INTOLERANCE 10 0.0001
657 ERUCTATION 2 0.0001
658 DIZZINESS POSTURAL 1 0.0001
659 DYSTONIA 2 0.0001
660 VISION BLURRED 14 0.0001
661 MENORRHAGIA 2 0.0001
662 ALOPECIA 20 0.0001
663 HEPATOMEGALY 1 0.0001
664 INSOMNIA 27 0.0001
665 LIGAMENT SPRAIN 1 0.0001
666 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
667 ABNORMAL BEHAVIOUR 4 0.0001
668 BLOOD PRESSURE ABNORMAL 2 0.0001
669 PRESCRIBED UNDERDOSE 2 0.0001
670 FEELING ABNORMAL 24 0.0001
671 BRAIN INJURY 1 0.0001
672 CYTOKINE RELEASE SYNDROME 2 0.0001
673 CELLULITIS 5 0.0001
674 INJURY ASSOCIATED WITH DEVICE 2 0.0001
675 EUPHORIC MOOD 1 0.0001
676 EAR DISCOMFORT 1 0.0001
677 FEMUR FRACTURE 3 0.0001
678 HYPERBILIRUBINAEMIA 1 0.0001
679 RHABDOMYOLYSIS 4 0.0001
680 DRUG-INDUCED LIVER INJURY 3 0.0001
681 DERMATITIS 2 0.0001
682 WITHDRAWAL SYNDROME 4 0.0001
683 INJECTION SITE DISCOMFORT 1 0.0001
684 HALLUCINATION, VISUAL 2 0.0001
685 DECREASED APPETITE 22 0.0001
686 BRONCHITIS 7 0.0001
687 FULL BLOOD COUNT ABNORMAL 1 0.0001
688 HYPERTENSION 20 0.0001
689 EATING DISORDER 2 0.0001
690 RETCHING 2 0.0001
691 JOINT INJURY 2 0.0001
692 IMPAIRED WORK ABILITY 2 0.0001
693 HIP FRACTURE 3 0.0001
694 HEREDITARY ANGIOEDEMA 1 0.0001
695 HYPERHIDROSIS 12 0.0001
696 PRURITUS GENERALISED 2 0.0001
697 DEVICE DISLOCATION 4 0.0001
698 BIPOLAR DISORDER 1 0.0001
699 BACK INJURY 1 0.0001
700 CHOLELITHIASIS 3 0.0001
701 DYSPEPSIA 9 0.0001
702 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
703 ASPIRATION 1 0.0001
704 STAPHYLOCOCCAL INFECTION 3 0.0001
705 INJECTION SITE NODULE 1 0.0001
706 EXPIRED PRODUCT ADMINISTERED 3 0.0001
707 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
708 FOOT DEFORMITY 1 0.0001
709 VIRAL INFECTION 3 0.0001
710 SKIN DISORDER 3 0.0001
711 RASH MACULO-PAPULAR 2 0.0001
712 HYPERTENSIVE CRISIS 1 0.0001
713 GLOSSODYNIA 2 0.0001
714 VOMITING 42 0.0001
715 SNEEZING 2 0.0001
716 PANCREATITIS ACUTE 2 0.0001
717 FISTULA 1 0.0001
718 BLOOD CALCIUM DECREASED 1 0.0001
719 VISUAL IMPAIRMENT 11 0.0001
720 CHROMATURIA 2 0.0001
721 EYE INFECTION 1 0.0001
722 FLUSHING 9 0.0001
723 PRODUCT DOSE OMISSION ISSUE 26 0.0001
724 MUSCULAR WEAKNESS 10 0.0001
725 DERMATITIS CONTACT 1 0.0001
726 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
727 SKIN DISCOLOURATION 4 0.0001
728 HYPOAESTHESIA 13 0.0001
729 PRODUCT SUBSTITUTION ISSUE 5 0.0001
730 COVID-19 PNEUMONIA 1 0.0001
731 ARRHYTHMIA 4 0.0001
732 BACTERAEMIA 1 0.0001
733 CATARACT 5 0.0001
734 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
735 MACULAR DEGENERATION 1 0.0001
736 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
737 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
738 SKIN EXFOLIATION 7 0.0001
739 CRYING 3 0.0001
740 MENTAL IMPAIRMENT 2 0.0001
741 STOMATITIS 5 0.0001
742 CONDITION AGGRAVATED 25 0.0001
743 CYTOPENIA 1 0.0001
744 CARDIOMEGALY 1 0.0001
745 HEART RATE INCREASED 8 0.0001
746 INFLUENZA 9 0.0001
747 ILEUS 1 0.0001
748 WEIGHT INCREASED 18 0.0001
749 HAIR COLOUR CHANGES 1 0.0001
750 AGEUSIA 2 0.0001
751 INJECTION SITE DISCOLOURATION 1 0.0001
752 MUSCULOSKELETAL STIFFNESS 7 0.0001
753 PAIN 49 0.0001
754 INTESTINAL OBSTRUCTION 3 0.0001
755 DEPRESSION 18 0.0001
756 FLUID RETENTION 4 0.0001
757 INJECTION SITE IRRITATION 1 0.0001
758 HEPATITIS 2 0.0001
759 ERECTILE DYSFUNCTION 2 0.0001
760 DRUG RESISTANCE 2 0.0001
761 DEEP VEIN THROMBOSIS 5 0.0001
762 PLASMA CELL MYELOMA 3 0.0001
763 CHILLS 9 0.0001
764 SEDATION 2 0.0001
765 JOINT STIFFNESS 2 0.0001
766 BEDRIDDEN 1 0.0001
767 GASTRITIS 2 0.0001
768 ANKYLOSING SPONDYLITIS 1 0.0001
769 PRURITUS 29 0.0001
770 SWELLING 7 0.0001
771 INJECTION SITE PRURITUS 5 0.0001
772 MALIGNANT MELANOMA 1 0.0001
773 THROMBOSIS 6 0.0001
774 ASTHENIA 28 0.0001
775 JAUNDICE 2 0.0001
776 DISTURBANCE IN ATTENTION 4 0.0001
777 THROAT TIGHTNESS 2 0.0001
778 OEDEMA PERIPHERAL 9 0.0001
779 DYSKINESIA 3 0.0001
780 LIMB INJURY 2 0.0001
781 NEUTROPHIL COUNT DECREASED 3 0.0001
782 GINGIVAL BLEEDING 1 0.0001
783 ACUTE HEPATIC FAILURE 1 0.0001
784 SKIN LESION 2 0.0001
785 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
786 FEELING COLD 2 0.0001
787 APHONIA 1 0.0001
788 NECK PAIN 4 0.0001
789 PERIPHERAL SWELLING 11 0.0001
790 BLOOD TEST ABNORMAL 1 0.0001
791 INJURY 5 0.0001
792 DEVICE OCCLUSION 1 0.0001
793 LYMPHOPENIA 1 0.0001
794 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
795 HYPERSENSITIVITY 13 0.0001
796 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
797 PRODUCT USE ISSUE 13 0.0001
798 VAGINAL HAEMORRHAGE 3 0.0001
799 ANOSMIA 1 0.0001
800 LIVER FUNCTION TEST ABNORMAL 2 0.0001
801 NEEDLE ISSUE 2 0.0001
802 ANAEMIA 13 0.0001
803 PSYCHOTIC DISORDER 2 0.0001
804 COLON CANCER 1 0.0001
805 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
806 RESPIRATORY DISORDER 2 0.0001
807 EPISTAXIS 5 0.0001
808 IRRITABILITY 4 0.0001
809 BLOOD POTASSIUM DECREASED 2 0.0001
810 HOT FLUSH 5 0.0001
811 APHASIA 2 0.0001
812 DEVICE FAILURE 1 0.0001
813 PLATELET COUNT DECREASED 7 0.0001
814 HIP ARTHROPLASTY 1 0.0001
815 FEELING HOT 4 0.0001
816 OROPHARYNGEAL PAIN 6 0.0001
817 LIMB DISCOMFORT 2 0.0001
818 PAIN IN EXTREMITY 19 0.0001
819 OCULAR HYPERAEMIA 3 0.0001
820 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
821 DRUG INTERACTION 10 0.0001
822 MOOD SWINGS 2 0.0001
823 GAIT DISTURBANCE 12 0.0001
824 ABSCESS 1 0.0001
825 LOSS OF CONSCIOUSNESS 8 0.0001
826 RASH 27 0.0001
827 RHINORRHOEA 4 0.0001
828 BLOOD POTASSIUM INCREASED 1 0.0001
829 EYE DISORDER 2 0.0001
830 TREMOR 10 0.0001
831 ARTHRALGIA 25 0.0001
832 COAGULOPATHY 1 0.0001
833 URINARY RETENTION 2 0.0001
834 DRY SKIN 8 0.0001
835 ANGER 2 0.0001
836 INJECTION SITE PAIN 18 0.0001
837 METRORRHAGIA 1 0.0001
838 HAEMATURIA 2 0.0001
839 GASTRIC DISORDER 2 0.0001
840 DEVICE DEFECTIVE 1 0.0001
841 NEOPLASM PROGRESSION 2 0.0001
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
843 SPEECH DISORDER 3 0.0001
844 COLD SWEAT 1 0.0001
845 INJECTION SITE ERYTHEMA 7 0.0001
846 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
847 ISCHAEMIC STROKE 1 0.0001
848 GALLBLADDER DISORDER 1 0.0001
849 LEUKOCYTOSIS 1 0.0001
850 DRUG EFFECT INCOMPLETE 2 0.0001
851 HYPOTENSION 11 0.0001
852 END STAGE RENAL DISEASE 1 0.0001
853 HAEMATOCHEZIA 3 0.0001
854 SEPSIS 6 0.0001
855 EYE SWELLING 2 0.0001
856 FOOT FRACTURE 1 0.0001
857 BLOOD URINE PRESENT 1 0.0001
858 CHRONIC KIDNEY DISEASE 4 0.0001
859 DIABETES MELLITUS 4 0.0001
860 INCREASED APPETITE 1 0.0001
861 INJECTION SITE SWELLING 4 0.0001
862 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
863 EYE IRRITATION 3 0.0001
864 HERNIA 1 0.0001
865 NEUTROPENIA 7 0.0001
866 CHOKING 1 0.0001
867 KIDNEY INFECTION 1 0.0001
868 MEMORY IMPAIRMENT 7 0.0001
869 HAEMATOCRIT DECREASED 1 0.0001
870 INJECTION SITE BRUISING 4 0.0001
871 FULL BLOOD COUNT DECREASED 1 0.0000
872 SUICIDE ATTEMPT 3 0.0000
873 PSORIATIC ARTHROPATHY 2 0.0000
874 BONE MARROW FAILURE 1 0.0000
875 BODY TEMPERATURE INCREASED 1 0.0000
876 INJECTION SITE WARMTH 1 0.0000
877 INCORRECT DOSE ADMINISTERED 11 0.0000
878 INTENTIONAL DRUG MISUSE 1 0.0000
879 KNEE ARTHROPLASTY 1 0.0000
880 INTENTIONAL OVERDOSE 3 0.0000
881 LIVER FUNCTION TEST INCREASED 1 0.0000
882 DEVICE LEAKAGE 2 0.0000
883 AMNESIA 3 0.0000
884 MENTAL DISORDER 2 0.0000
885 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
886 INFUSION RELATED REACTION 3 0.0000
887 NEOPLASM MALIGNANT 3 0.0000
888 THERAPY NON-RESPONDER 2 0.0000
889 PYREXIA 15 0.0000
890 PNEUMONIA 14 0.0000
891 RENAL DISORDER 2 0.0000
892 DYSPHAGIA 4 0.0000
893 THERAPY INTERRUPTED 3 0.0000
894 URTICARIA 7 0.0000
895 DIABETIC KETOACIDOSIS 1 0.0000
896 INFECTION 6 0.0000
897 INJECTION SITE URTICARIA 1 0.0000
898 ENCEPHALOPATHY 1 0.0000
899 DRY EYE 2 0.0000
900 LEUKOPENIA 2 0.0000
901 GASTRIC CANCER 1 0.0000
902 CARDIOVASCULAR DISORDER 1 0.0000
903 THERAPY CESSATION 2 0.0000
904 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
905 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
906 DIPLOPIA 1 0.0000
907 DEAFNESS 1 0.0000
908 PRODUCT QUALITY ISSUE 5 0.0000
909 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
910 ABNORMAL DREAMS 1 0.0000
911 TREATMENT FAILURE 3 0.0000
912 MENTAL STATUS CHANGES 1 0.0000
913 BLISTER 2 0.0000
914 OFF LABEL USE 31 0.0000
915 HERPES ZOSTER 2 0.0000
916 SEIZURE 4 0.0000
917 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
918 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
919 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
920 SURGERY 2 0.0000
921 LABORATORY TEST ABNORMAL 1 0.0000
922 DISEASE PROGRESSION 4 0.0000
923 DEVICE ISSUE 3 0.0000
924 THERAPEUTIC RESPONSE DECREASED 2 0.0000
925 ILL-DEFINED DISORDER 2 0.0000
926 PLEURAL EFFUSION 2 0.0000
927 EPILEPSY 1 0.0000
928 INJECTION SITE RASH 1 0.0000
929 HOSPITALISATION 5 0.0000
930 EMOTIONAL DISORDER 1 0.0000
931 BONE DENSITY DECREASED 1 0.0000
932 BLOOD GLUCOSE INCREASED 6 0.0000
933 HEAD INJURY 1 0.0000
934 CYSTITIS 1 0.0000
935 HYPOTHYROIDISM 1 0.0000
936 PRODUCT DOSE OMISSION 2 0.0000
937 EYE PRURITUS 1 0.0000
938 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
939 DRUG INEFFECTIVE 39 0.0000
940 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
941 HEPATIC ENZYME INCREASED 2 0.0000
942 ERYTHEMA 6 0.0000
943 LYMPHADENOPATHY 1 0.0000
944 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
945 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
946 CEREBRAL HAEMORRHAGE 1 0.0000
947 SKIN BURNING SENSATION 2 0.0000
948 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
949 HYPERGLYCAEMIA 1 0.0000
950 UNDERDOSE 2 0.0000
951 INJECTION SITE MASS 1 0.0000
952 THROMBOCYTOPENIA 3 0.0000
953 HEPATIC FUNCTION ABNORMAL 1 0.0000
954 RHEUMATOID ARTHRITIS 3 0.0000
955 INJECTION SITE HAEMORRHAGE 2 0.0000
956 CARDIAC FAILURE 2 0.0000
957 CARDIAC FAILURE CONGESTIVE 2 0.0000
958 EMOTIONAL DISTRESS 3 0.0000
959 EXTRA DOSE ADMINISTERED 1 0.0000
960 CARDIO-RESPIRATORY ARREST 1 0.0000
961 RENAL FAILURE 3 0.0000
962 LIVER DISORDER 1 0.0000
963 ADVERSE DRUG REACTION 2 0.0000
964 NO ADVERSE EVENT 4 0.0000
965 PULMONARY EMBOLISM 2 0.0000
966 DISEASE RECURRENCE 1 0.0000
967 COMA 1 0.0000
968 BLOOD GLUCOSE DECREASED 1 0.0000
969 LUNG DISORDER 1 0.0000
970 AGGRESSION 1 0.0000
971 HAEMOGLOBIN DECREASED 2 0.0000
972 HAEMORRHAGE 2 0.0000
973 ARTHROPATHY 1 0.0000
974 MEDICATION ERROR 1 0.0000
975 CEREBROVASCULAR ACCIDENT 3 0.0000
976 MYOCARDIAL INFARCTION 3 0.0000
977 BONE PAIN 1 0.0000
978 DEVICE DIFFICULT TO USE 1 0.0000
979 FEBRILE NEUTROPENIA 1 0.0000
980 INJECTION SITE REACTION 1 0.0000
981 DEVICE MALFUNCTION 1 0.0000
982 OVERDOSE 3 0.0000
983 ACNE 1 0.0000
984 DRUG WITHDRAWAL SYNDROME 1 0.0000
985 ADVERSE EVENT 1 0.0000
986 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
987 DEATH 8 0.0000
988 DRUG DEPENDENCE 1 0.0000
989 DRUG DOSE OMISSION 1 0.0000